When it comes to the drama category at the upcoming Emmy Awards, there’s only one question when it comes to The Pitt: Not if it will get nominations, but how many nominations will it get. More than last year, when it converted five of its 13 Emmy nominations into wins.
So instead, our panel of experts — Deadline’s Pete Hammond, The Hollywood Reporter‘s Scott Feinberg, IndieWire’s Marcus Jones, and Variety‘s Clayton Davis, in a conversation moderated by Gold Derby’s editor-in-chief Debra Birnbaum — debated which series will be vying for bragging rights against the juggernaut HBO medical drama.
With eight slots in the category, the pundits (mostly) agreed on five contenders: Paradise, Pluribus, The Diplomat, and Slow Horses. But from there, the conversation took a fierce turn — with a looooong list of titles vying for those remaining slots, including Task, The Gilded Age, Stranger Things, The Morning Show, and Euphoria.
“I’m genuinely curious: A lot of folks here have have placed in their top eight A Night of the Seven Kingdoms,” asks Feinberg. “Is that just a default because it’s a big HBO show?”
Jones advocates for another HBO title, Industry. “I think that that’s a huge critical favorite that’s gotten a really big push,” he says. “They finally came to L.A. to really engage with the voter base, and you’re seeing them across all the FYC stuff.”
And then there’s Landman and The Madison. “Taylor Sheridan is the big unopened envelope,” says Hammond. “Most people voting are actors in programs, so I think that those shows benefit. He is giving more jobs to big name actors than anybody ever seen.”
Which actress is confronting “her year to get knocked out”? Who should get the fifth Best Drama Actor slot but not enough people saw his show? And just how many Pitt stars will get Best Supporting Actor and Actress nominations?
Watch the full drama debate in the video above, and catch up with the limited series debate here and the comedy panel here. The Emmy nominations will be announced on July 8.
